Medical Research News

RSS

Researcher pinpoints error in protein formation that could be root of amyotrophic lateral sclerosis

By studying nerve cells that originated in patients with a severe neurological disease, a University of Wisconsin-Madison researcher has pinpointed an error in protein formation that could be the root of amyotrophic lateral sclerosis.

4 Apr 2014

Kidney disease patients with poor quality of life at increased risk of developing heart problems

Kidney disease patients with poor quality of life are at increased risk of experiencing progression of their disease and of developing heart problems, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology. The findings suggest that quality of life measurements may have important prognostic value in these individuals.

4 Apr 2014

Eating watermelon reduces blood pressure in overweight individuals

Be sure to pick up a watermelon - or two - at your neighborhood farmers' market. It could save your life.

4 Apr 2014

Sanford-Burnham to present new cancer research data at AACR 2014

Sanford-Burnham Medical Research Institute will present a wide range of new research data at the annual American Association for Cancer Research Meeting in San Diego starting Saturday, April 5, at the San Diego Convention Center. The presentations will cover a variety of topics including breast, melanoma, and prostate cancer, as well as novel methods of delivering drugs to tumors.

4 Apr 2014

Researchers receive President of Ireland Young Researcher Award from Science Foundation Ireland

President of Ireland, Michael D. Higgins, has today received three recipients of the Science Foundation Ireland, President of Ireland Young Researcher Award (PIYRA) at áras an Uachtaráin.

4 Apr 2014

Scientists develop new resuscitation protocols for birth asphyxia seizures

During birth, the baby has to stop depending on the placenta and start breathing on his or her own. If there are problems during the birth process, the baby may spend a period of time in the pathological condition of asphyxia, where the oxygen levels in the blood are much lower and carbon dioxide levels are much higher than expected.

4 Apr 2014

Researchers develop new eco repellent that stops mosquitoes from attacking humans

This year's World Health Day (April 7th) focuses on vector-borne diseases, like malaria. Malaria still kills more than half a million people every year, mainly children. In the battle against this disease researchers in Switzerland have developed a new eco repellent that stops mosquitoes from attacking humans.

4 Apr 2014

Harvard stem cell scientists discover potential treatment for amyotrophic lateral sclerosis

Harvard stem cell scientists have discovered that a recently approved medication for epilepsy may possibly be a meaningful treatment for amyotrophic lateral sclerosis (ALS)-Lou Gehrig's disease, a uniformly fatal neurodegenerative disorder. The researchers are now collaborating with Massachusetts General Hospital to design an initial clinical trial testing the safety of the treatment in ALS patients.

4 Apr 2014

Study reveals role of dopamine in hippocampus region of brain

Bruno Giros, PhD, a researcher at the Douglas Mental Health University Institute and a professor in the Department of Psychiatry at McGill University, has demonstrated, for the first time, the role that dopamine plays in a region of the brain called the hippocampus.

4 Apr 2014

Metabolon announces launch of fourth-generation metabolomics platform

Metabolon, Inc., a leader in metabolomics-driven biomarker discovery, announced today the launch of DiscoveryHD4, the company's fourth-generation metabolomics platform.

4 Apr 2014

UCSF/Daiichi Sankyo establish drug-discovery collaboration focused on neurodegenerative diseases

Daiichi Sankyo Co., Ltd. (hereafter, Daiichi Sankyo) and UC San Francisco (UCSF) announced today that they have established a drug-discovery collaboration focused on developing novel therapeutics and molecular diagnostics for multiple neurodegenerative diseases.

4 Apr 2014

Scientists battle against cancer with nanoballoons and lasers

Chemotherapeutic drugs excel at fighting cancer, but they're not so efficient at getting where they need to go.

4 Apr 2014

Fourth Herbert A. Fleisch ESCEO-IOF Medal awarded to Belgian researcher at Ghent University Hospital

The 4th Herbert A. Fleisch ESCEO-IOF Medal was awarded today to eminent Belgian researcher Jean-Marc Kaufman, Professor of Medicine at the Ghent University Hospital, Ghent, Belgium.

4 Apr 2014

Cognitive dysfunction reflected in schizophrenia healthcare costs

Cognitive dysfunction has direct and indirect effects on healthcare costs in patients with schizophrenia, research suggests.

3 Apr 2014

Excessive alcohol use does not alter course of bipolar mood states

Patients with bipolar disorder who consume alcohol do not experience significant changes in their self-reported mood states with increased consumption, show Dutch study findings.

3 Apr 2014

Transplant drugs may help defeat HIV

Drugs that are currently given to prevent organ rejection in patients who have received a transplant may offer a new approach to curing HIV, say researchers.

3 Apr 2014

Researchers examine risks and benefits of E-cigarettes

Some believe e-cigarettes are less harmful than smoking tobacco since e-cig vapor doesn't contain the chemicals found in tobacco smoke.

3 Apr 2014

Adherent Health announces results of 2014 Patient Preference Study

Adherent Health, LLC, a mobile health engagement advisory focused on medication safe-use, adherence, and health outcomes attainment, announced today the results of its 2014 Patient Preference Study which surveyed the mobile app behaviors and medication support preferences of 2,216 prescription-taking patients aged 18-65+.

3 Apr 2014

Crescendo raises additional £2M ($3.3M) in final close of Series A financing from EMBL Ventures

Crescendo Biologics Limited today announces it has raised a further £2m ($3.3m), from EMBL Ventures, in a final close of its Series A financing. Originally announced in December 2013, the Series A now totals £19.5m. It was led by Imperial Innovations and included new investor Astellas Venture Management. Founding seed investor Sofinnova Partners also contributed significantly to the round.

3 Apr 2014

Ketamine offers novel treatment for patients with severe depression

New data show ketamine (a drug widely used for anaesthesia and pain relief) has a rapid antidepressant effect in some patients with severe depression. The first UK study of ketamine intravenous infusions in people with treatment-resistant depression was conducted by the Oxford Health NHS Foundation Trust and the University of Oxford.

3 Apr 2014

Medical Research News

Researcher pinpoints error in protein formation that could be root of amyotrophic lateral sclerosis

Kidney disease patients with poor quality of life at increased risk of developing heart problems

Eating watermelon reduces blood pressure in overweight individuals

Sanford-Burnham to present new cancer research data at AACR 2014

Researchers receive President of Ireland Young Researcher Award from Science Foundation Ireland

Scientists develop new resuscitation protocols for birth asphyxia seizures

Researchers develop new eco repellent that stops mosquitoes from attacking humans

Harvard stem cell scientists discover potential treatment for amyotrophic lateral sclerosis

Study reveals role of dopamine in hippocampus region of brain

Metabolon announces launch of fourth-generation metabolomics platform

UCSF/Daiichi Sankyo establish drug-discovery collaboration focused on neurodegenerative diseases

Scientists battle against cancer with nanoballoons and lasers

Fourth Herbert A. Fleisch ESCEO-IOF Medal awarded to Belgian researcher at Ghent University Hospital

Cognitive dysfunction reflected in schizophrenia healthcare costs

Excessive alcohol use does not alter course of bipolar mood states

Transplant drugs may help defeat HIV

Researchers examine risks and benefits of E-cigarettes

Adherent Health announces results of 2014 Patient Preference Study

Crescendo raises additional £2M ($3.3M) in final close of Series A financing from EMBL Ventures

Ketamine offers novel treatment for patients with severe depression

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog

Latest News